Chromoblastomycosis: clinical presentation and management

被引：75

作者：

Ameen, M. ^{[1
]}

机构：

[1] Guys & St Thomas NHS Trust, St Johns Inst Dermatol, London SE1 7EH, England

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2009年 / 34卷 / 08期

关键词：

AMPHOTERICIN-B; ITRACONAZOLE; TERBINAFINE; CHROMOMYCOSIS; EXPERIENCE; FONSECAEA; PHEOHYPHOMYCOSIS; IDENTIFICATION; COMBINATION; CRYOSURGERY;

D O I：

10.1111/j.1365-2230.2009.03415.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100227 [皮肤病学];

摘要：

Chromoblastomycosis is an important subcutaneous mycotic infection that is endemic worldwide but more common in the tropics. It is caused by the traumatic inoculation of the skin with pigmented saprophytic moulds, and the principal infective species are Fonsecaea pedrosoi and Cladophialophora carrionii. Although chromoblastomycosis is not known to be fatal, it is characteristically chronic, and can be complicated by lymphatic damage and neoplastic transformation. It is one of the more difficult-to-treat mycoses, and a variety of antifungal regimens often combined with various physical treatments can be used.

引用

收藏

页码：849 / 854

页数：6

相关论文

共 29 条

[1]

Specific oligonucleotide primers for identification of Cladophialophora carrionii, a causative agent of chromoblastomycosis [J].

Abliz, P ;

Fukushima, K ;

Takizawa, K ;

Nishimura, K .

JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (01) :404-407

[2]

Treatment of chromoblastomycosis with terbinafine:: Experience with four cases [J].

Bonifaz, A ;

Saúl, A ;

Paredes-Solis, V ;

Araiza, J ;

Fierro-Arias, L .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (01) :47-51

[3]

Treating chromoblastomycosis with systemic antifungals [J].

Bonifaz, A ;

Paredes-Solís, V ;

Saúl, A .

EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (02) :247-254

[4]

Treatment of chromoblastomycosis with itraconazole, cryosurgery, and a combination of both [J].

Bonifaz, A ;

MartinezSoto, E ;

CarrascoGerard, E ;

Peniche, J .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 1997, 36 (07) :542-547

[5]

Chromoblastomycosis:: clinical and mycologic experience of 51 cases [J].

Bonifaz, A ;

Carrasco-Gerard, E ;

Saúl, A .

MYCOSES, 2001, 44 (1-2) :1-7

[6]

In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs [J].

Caligiorne, RB ;

Resende, MA ;

Melillo, PHC ;

Peluso, CP ;

Carmo, FHS ;

Azevedo, V .

MEDICAL MYCOLOGY, 1999, 37 (06) :405-409

[7]

Treatment of chromomycosis by cryosurgery with liquid nitrogen: 15 years' experience [J].

Castro, LGM ;

Pimentel, ERA ;

Lacaz, CS .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2003, 42 (05) :408-412

[8]

Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis [J].

de Andrade, Tania Sueli ;

Cury, Arlete Emily ;

Martins de Castro, Luiz Guilherme ;

Hirata, Mario Hiroyuki ;

Crespo Hirata, Rosario Dominguez .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2007, 57 (03) :267-272

[9]

Management of chromoblastomycosis: novel perspectives [J].

Esterre, P ;

Queiroz-Telles, F .

CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (02) :148-152

[10]

Treatment of chromomycosis with terbinafine: Preliminary results of an open pilot study [J].

Esterre, P ;

Inzan, CK ;

Ramarcel, ER ;

Andriantsimahavandy, A ;

Ratsioharana, M ;

Pecarrere, JL ;

Roig, P .

BRITISH JOURNAL OF DERMATOLOGY, 1996, 134 :33-36